Here are the players #AACE2022 #Endotwitter
Food intake is not a cognitive function #aace2022 #Endotwitter
So complicated
Its been a journey, the development of #obesity meds. Some good, some bad #AACE2022 #Endotwitter
Efficacy of #obesity meds. Semaglutide "the new kid on the block" is still winning the race #AACE2022
semaglutide maintained weight loss at 2yrs (~16% TBW)
Semaglutide even better than liraglutide. Why is that? LIkely due to binding in brain
Its an exciting time as there is a lot of Ongoing research for #obesity pharm #AACE2022 #Endotwitter
New drug Tirzepatide with both really good glycemic effects (best results so far) along with weight loss
20% weight loss in those w/o diabetes. Amazing
Target differnt weight loss goals depending on #obesity related complication to help use weight loss as a treatment! Use TBW as the target, just like you would use mmHg as target for HTN. These weight loss medications can help achieve these targets! #AACE2022 #Endotwitter
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.